Urinary Bladder Cancer : NICE USC guidance summary

This table is designed to aid in the swift identification and appropriate referral of patients who may be at risk of bladder cancer, according to the specified criteria from 2015.

Criteria	Age Group	Symptoms and Conditions	Referral Type
1.6.4	45 and over	♦ Unexplained visible haematuria without urinary tract infection (UTI) ♦ Visible haematuria that persists or recurs after successful treatment of UTI	Suspected cancer pathway referral
	60 and over	♦ Unexplained non-visible haematuria ♦ Accompanied by either dysuria or a raised white cell count on a blood test	Suspected cancer pathway referral
1.6.5	60 and over	♦ Recurrent or persistent unexplained UTI	Consider non-urgent referral

Key Definitions:

Visible haematuria: Blood that is visible in the urine to the naked eye.
Non-visible haematuria: Blood in the urine that is not visible to the naked eye but is detected through a test *
Dysuria: Painful or difficult urination.
Raised white cell count: Indicative of infection or other inflammatory conditions, detected through a blood test.

Non-visible haematuria, also known as microscopic haematuria, is detected through urine tests rather than being visible to the naked eye. The primary tests used to identify non-visible haematuria include:

Urine Dipstick Test: A quick and initial screening...

Try our Free Plan to get the full article.